Cleared Special

K110010 - NEUROPORT CORTICAL MICROELECTRODE ARRAY SYSTEM

K110010 is an FDA 510(k) clearance for NEUROPORT CORTICAL MICROELECTRODE ARRAY..., manufactured by Blackrock Microsystems, Inc.. The device is a Class 2 Neurology device with product code GZL cleared through the Special 510(k) pathway after a 37-day FDA review.

K110010 · Blackrock Microsystems, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2011
Decision
37d
Days
Class 2
Risk

K110010 is an FDA 510(k) clearance for the NEUROPORT CORTICAL MICROELECTRODE ARRAY SYSTEM. Classified as Electrode, Depth (product code GZL), Class II - Special Controls.

Submitted by Blackrock Microsystems, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on February 9, 2011 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1330 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Blackrock Microsystems, Inc. devices

FDA 510(k) Submission Details - K110010

510(k) Number K110010 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 2011
Decision Date February 09, 2011
Days to Decision 37 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 148d · This submission: 37d
Pathway characteristics
Modification to existing cleared device.

GZL Device Classification - Class 2, Special Controls

Product Code GZL Electrode, Depth
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZL Electrode, Depth

All 31
Devices cleared under the same product code (GZL) and FDA review panel - the closest regulatory comparables to K110010.
microTargeting Guideline 4000 5.0 System
K183123 · FHC, Inc. · Dec 2018
Anchor Bolt (as an accessory to Depth Electrodes)
K181544 · Ad-Tech Medical Instrument Corporation · Aug 2018
NeuroNav System, NeuroSmart System
K172042 · Alpha Omega Engineering , Ltd. · Feb 2018
DEPTH ELECTRODE, FORAMEN OVALE DEPTH ELECTRODES, WYLER SPHENOIDAL DEPTH ELECTRODES
K053358 · Ad-Tech Medical Instrument Corp · May 2006
MACRO-MICRO DEPTH ELECTRODE
K041604 · Ad-Tech Medical Instrument Corp · Aug 2004
PMT SPHENOIDAL ELECTRODE AND ACCESSORY, MODEL 2101-31 AND 2102-31 SERIES
K033730 · Pmt Corp. · Aug 2004